Marc Boutin is the Chief Executive Officer of the National Health Council, the only organization that brings together all segments of the health community to provide a united voice for the more than 133 million people with chronic diseases and disabilities and their family caregivers.
Made up of more than 100 diverse national health-related organizations and businesses, the NHC's core membership includes the nation’s leading patient advocacy organizations, which control its governance and policy-making process. Other members include professional and membership associations, nonprofit organizations with an interest in health, and representatives from the pharmaceutical, generic drug, health insurance, device, biotechnology, and communication industries.
Mr Boutin has been a leading voice for greater patient involvement at every stage of the continuum, starting with the development of new drugs, to regulatory oversight of health care delivery, to shared decision-making at the point of care. Under his leadership, the NHC has convened a broad range of stakeholders to create and effectively implement pragmatic strategies and public policy that address diverse issues, such as enhancing patient engagement, advancing the development of new treatments, and developing a better health delivery system to meet the needs of people with chronic conditions.
Mr Boutin has a long history of Board and Committee service. Currently he serves as a member of the AdaptSmart International Advisory Board, NEST Governing Committee and Subcommittee Charter, Patient-Centered Research Foundation, Patient Focused Medicines Development (PFMD), MDIC Patient-Centered Benefit-Risk Steering Committee/Patient Engagement Steering Committee, and PhRMA Stakeholder Advisory Committee
Mr Boutin is a former civil rights litigator. He received his bachelor of economics degree in international politics/law from the University College of Wales, Aberystwyth, United Kingdom and his JD from Suffolk University Law School in Boston, Massachusetts.